These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26870717)

  • 41. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.
    Allen MR; Burr DB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):61-70. PubMed ID: 19371816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exposed necrotic bone in 183 patients with bisphosphonate-related osteonecrosis of the jaw: Associated clinical characteristics.
    Bagan L; Jiménez Y; Leopoldo M; Murillo-Cortes J; Bagan J
    Med Oral Patol Oral Cir Bucal; 2017 Sep; 22(5):e582-e585. PubMed ID: 28809382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implant failure associated with oral bisphosphonate-related osteonecrosis of the jaw.
    Shin EY; Kwon YH; Herr Y; Shin SI; Chung JH
    J Periodontal Implant Sci; 2010 Apr; 40(2):90-5. PubMed ID: 20498766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The outcome after surgical therapy of bisphosphonate-associated osteonecrosis of the jaw--results of a clinical case series with an average follow-up of 20 months.
    Stockmann P; Burger M; von Wilmowsky C; Ebker T; Lutz R; Bauersachs A; Nkenke E; Neukam FW; Wehrhan F
    Clin Oral Investig; 2014 May; 18(4):1299-1304. PubMed ID: 23989467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical analysis of bisphosphonate-related osteonecrosis of the jaw].
    Jiaxing G; Huiming W
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2016 Aug; 34(4):358-363. PubMed ID: 28317352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [New development in bisphosphonate treatment. Bisphosphonate therapy and osteonecrosis of the jaws].
    Urade M
    Clin Calcium; 2009 Jan; 19(1):100-8. PubMed ID: 19122270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.
    Koth VS; Figueiredo MA; Salum FG; Cherubini K
    Dentomaxillofac Radiol; 2016; 45(7):20160049. PubMed ID: 27167455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.
    Bedogni A; Bettini G; Totola A; Saia G; Nocini PF
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1662-6. PubMed ID: 20561470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice.
    Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
    Bone; 2018 Jul; 112():177-186. PubMed ID: 29729428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adipose-derived stem cells prevent the onset of bisphosphonate-related osteonecrosis of the jaw through transforming growth factor β-1-mediated gingival wound healing.
    Zang X; He L; Zhao L; He Y; Xiao E; Zhang Y
    Stem Cell Res Ther; 2019 Jun; 10(1):169. PubMed ID: 31196208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT; Chiang WF; Chuang CY; Chang SW
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.
    Nicolatou-Galitis O; Papadopoulou E; Sarri T; Boziari P; Karayianni A; Kyrtsonis MC; Repousis P; Barbounis V; Migliorati CA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):195-202. PubMed ID: 21622014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
    Lescaille G; Coudert AE; Baaroun V; Javelot MJ; Cohen-Solal M; Berdal A; Goudot P; Azérad J; Ruhin B; Descroix V
    J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - Prognostic factors in the treatment of BRONJ.
    Yoshiga D; Nakamichi I; Yamashita Y; Yamamoto N; Yamauchi K; Nogami S; Kaneuji T; Mitsugi S; Tanaka K; Kataoka Y; Sakurai T; Kiyomiya H; Miyamoto I; Takahashi T
    J Clin Exp Dent; 2014 Feb; 6(1):e22-8. PubMed ID: 24596631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.
    Song M; Alshaikh A; Kim T; Kim S; Dang M; Mehrazarin S; Shin KH; Kang M; Park NH; Kim RH
    J Endod; 2016 Nov; 42(11):1641-1646. PubMed ID: 27637460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metastatic cancer identified in osteonecrosis specimens of the jaws in patients receiving intravenous bisphosphonate medications.
    Carlson ER; Fleisher KE; Ruggiero SL
    J Oral Maxillofac Surg; 2013 Dec; 71(12):2077-86. PubMed ID: 23945512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients.
    Adamo V; Caristi N; Saccà MM; Ferraro G; Arcanà C; Maisano R; Santini D; Tonini G
    Expert Opin Pharmacother; 2008 Jun; 9(8):1351-61. PubMed ID: 18473709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws.
    Lee ES; Tsai MC; Lee JX; Wong C; Cheng YN; Liu AC; Liang YF; Fang CY; Wu CY; Lee IT
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
    Nomura T; Shibahara T; Uchiyama T; Yamamoto N; Shibui T; Yakushiji T; Watanabe A; Muramatsu K; Ogane S; Murayama M; Sekine R; Nakata E; Fujimoto Y
    Bull Tokyo Dent Coll; 2013; 54(2):117-25. PubMed ID: 23903583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current management concepts for bisphosphonate-related osteonecrosis of the jaw: a review.
    Kilic E; Doganay O
    Gen Dent; 2018; 66(6):e1-e5. PubMed ID: 30444713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.